Commonwealth Bank of Australia’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,033
| Closed | -$945K | – | 741 |
|
|
2019
Q2 | $945K | Sell |
3,033
-44
| -1% | -$13.7K | 0.01% | 574 |
|
|
2019
Q1 | $1.26M | Buy |
3,077
+1,000
| +48% | +$409K | 0.01% | 506 |
|
|
2018
Q4 | $770K | Buy |
2,077
+1,406
| +210% | +$521K | 0.01% | 545 |
|
|
2018
Q3 | $268K | Buy |
671
+600
| +845% | +$240K | ﹤0.01% | 860 |
|
|
2018
Q2 | $23K | Buy |
71
+30
| +73% | +$9.72K | ﹤0.01% | 729 |
|
|
2018
Q1 | $12K | Hold |
41
| – | – | ﹤0.01% | 746 |
|
|
2017
Q4 | $14K | Sell |
41
-1
| -2% | -$341 | ﹤0.01% | 739 |
|
|
2017
Q3 | $17K | Sell |
42
-302
| -88% | -$122K | ﹤0.01% | 724 |
|
|
2017
Q2 | $167K | Sell |
344
-13
| -4% | -$6.31K | ﹤0.01% | 647 |
|
|
2017
Q1 | $138K | Buy |
357
+8
| +2% | +$3.09K | ﹤0.01% | 639 |
|
|
2016
Q4 | $128K | Buy |
349
+81
| +30% | +$29.7K | ﹤0.01% | 609 |
|
|
2016
Q3 | $108K | Hold |
268
| – | – | ﹤0.01% | 622 |
|
|
2016
Q2 | $93K | Sell |
268
-2
| -0.7% | -$694 | ﹤0.01% | 626 |
|
|
2016
Q1 | $97K | Buy |
270
+28
| +12% | +$10.1K | ﹤0.01% | 634 |
|
|
2015
Q4 | $132K | Buy |
242
+28
| +13% | +$15.3K | ﹤0.01% | 643 |
|
|
2015
Q3 | $100K | Buy |
214
+3
| +1% | +$1.4K | ﹤0.01% | 656 |
|
|
2015
Q2 | $108K | Buy |
211
+11
| +6% | +$5.63K | ﹤0.01% | 608 |
|
|
2015
Q1 | $90K | Hold |
200
| – | – | ﹤0.01% | 603 |
|
|
2014
Q4 | $82K | Sell |
200
-1,600
| -89% | -$656K | ﹤0.01% | 597 |
|
|
2014
Q3 | $649K | Hold |
1,800
| – | – | 0.01% | 557 |
|
|
2014
Q2 | $508K | Sell |
1,800
-8,683
| -83% | -$2.45M | 0.01% | 579 |
|
|
2014
Q1 | $3.15M | Buy |
10,483
+1,531
| +17% | +$460K | 0.02% | 553 |
|
|
2013
Q4 | $2.46M | Buy |
8,952
+592
| +7% | +$163K | 0.02% | 585 |
|
|
2013
Q3 | $2.62M | Buy |
8,360
+730
| +10% | +$228K | 0.02% | 535 |
|
|
2013
Q2 | $1.72M | Buy |
+7,630
| New | +$1.72M | 0.01% | 605 |
|